Guy Meno‐Tetang
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Neurology top 5%
- Neuroblastoma Research and Treatments
Papers in
-
- Sphingolipid Metabolism and Signaling 2
- RNA Interference and Gene Delivery 2
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Ian Lewis (1 shared paper)U. Briner (1 shared paper)Christian Bruns (1 shared paper)Gisbert Weckbecker (1 shared paper)Philip J. Lowe (2 shared papers)William J. Jusko (3 shared papers)Dhaval K. Shah (5 shared papers)Hongshan Li (2 shared papers)
- Journals
- Journal of Pharmacokinetics and Pharmacodynamics (4 papers)Journal of Pharmaceutical Sciences (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Acta Neuropathologica (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Guy Meno‐Tetang
20 papers receiving 1.2k citations
Guy Meno‐Tetang's Hit Papers
Peers
Comparison fields: 5 of 91
- Endocrinology, Diabetes and Metabolism 356
- Neurology 231
- Epidemiology 347
- Oncology 238
- Physiology 218
Countries citing papers authored by Guy Meno‐Tetang
This map shows the geographic impact of Guy Meno‐Tetang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Meno‐Tetang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Meno‐Tetang more than expected).
Fields of papers citing papers by Guy Meno‐Tetang
This network shows the impact of papers produced by Guy Meno‐Tetang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Meno‐Tetang. The network helps show where Guy Meno‐Tetang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy Meno‐Tetang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile Hit paper breakdown → | 2002 | 555 |
| 2 | 2019 | 122 | |
| 3 | 2006 | 119 | |
| 4 | 2005 | 77 | |
| 5 | 2019 | 58 | |
| 6 | 2021 | 52 | |
| 7 | 2018 | 51 | |
| 8 | 2012 | 44 | |
| 9 | 2022 | 28 | |
| 10 | 2007 | 28 | |
| 11 | 2015 | 27 | |
| 12 | 2002 | 26 | |
| 13 | 2019 | 22 | |
| 14 | 2022 | 9 | |
| 15 | 1996 | 8 | |
| 16 | 1999 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 1999 | 3 | |
| 20 | 2025 | 1 |
About Guy Meno‐Tetang
Guy Meno‐Tetang is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Physiology, Genetics and Oncology, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Virus-based gene therapy research (4 papers), Alzheimer's disease research and treatments (2 papers), Hormonal and reproductive studies (2 papers), CAR-T cell therapy research (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Sphingolipid Metabolism and Signaling (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (356 citations), Neurology (231 citations), Epidemiology (347 citations), Oncology (238 citations) and Physiology (218 citations). Guy Meno‐Tetang has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Ian Lewis, U. Briner, Christian Bruns, Gisbert Weckbecker, Philip J. Lowe, William J. Jusko, Dhaval K. Shah, Hongshan Li, Peter Heining and Charles Duyckaerts. Their work appears in journals such as Journal of Pharmacokinetics and Pharmacodynamics, Journal of Pharmaceutical Sciences, CPT Pharmacometrics & Systems Pharmacology, Journal of Pharmacology and Experimental Therapeutics and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.